Immunogen | Salgsomkostninger Og Administration

Selling And Administration Expenses Lave om Dato
AbbVie USD 3.61B 273M 2023-12
Agios Pharmaceuticals USD 35.3M 9.48M 2023-12
Amgen USD 1.76B 424M 2023-12
Astellas Pharma JPY 179.28B 11.1B 2023-09
AstraZeneca USD 3.91B 194M 2023-09
Bristol-Myers Squibb USD 2.06B 126M 2023-12
Eli Lilly USD 1.92B 120.7M 2023-12
Exelixis USD 138.14M 3.58M 2023-09
Halozyme Therapeutics USD 37.61M 2.34M 2023-12
Pfizer USD 4.47B 1.27B 2023-12
Regeneron Pharmaceuticals USD 737.7M 97.2M 2023-12
Roche Holding CHF 6.51B 26M 2023-06



Immunogen Salgsomkostninger Og Administration - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Apr 2024.